EF
BIIB icon

Empowered Funds’s Biogen BIIB Stock Holding History

Empowered Funds’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74M Buy
21,948
+173
+0.8% +$33.1K 0.03% 734
2026
Q1 		$3.99M Sell
21,775
-36,186
-62% -$6.67M 0.03% 739
2025
Q4 		$10.2M Buy
57,961
+48,918
+541% +$7.99M 0.17% 132
2025
Q3 		$1.27M Buy
9,043
+700
+8% +$94.6K 0.01% 1102
2025
Q2 		$1.05M Buy
8,343
+1,289
+18% +$161K 0.01% 1051
2025
Q1 		$965K Buy
7,054
+2,777
+65% +$397K 0.01% 1011
2024
Q4 		$654K Sell
4,277
-14,631
-77% -$2.47M 0.01% 1081
2024
Q3 		$3.67M Buy
18,908
+15,506
+456% +$3.24M 0.06% 460
2024
Q2 		$789K Sell
3,402
-6,992
-67% -$1.52M 0.01% 929
2024
Q1 		$2.24M Buy
10,394
+7,887
+315% +$1.85M 0.04% 571
2023
Q4 		$649K Buy
2,507
+585
+30% +$144K 0.02% 929
2023
Q3 		$494K Buy
1,922
+412
+27% +$110K 0.01% 924
2023
Q2 		$430K Buy
1,510
+422
+39% +$126K 0.02% 863
2023
Q1 		$302K Buy
+1,088
New +$301K 0.02% 451
2021
Q2 		– Sell
-11,138
Closed -$2.73M – 231
2021
Q1 		$2.73M Hold
11,138
– – 0.52% 58
2020
Q4 		$2.73M Buy
11,138
+697
+7% +$180K 0.52% 58
2020
Q3 		$2.96M Buy
10,441
+1,378
+15% +$384K 0.92% 21
2020
Q2 		$2.42M Buy
9,063
+457
+5% +$137K 0.94% 44
2020
Q1 		$2.55M Hold
8,606
– – 0.92% 32
2019
Q4 		$2.55M Sell
8,606
-1,175
-12% -$326K 0.92% 32
2019
Q3 		$2.28M Buy
9,781
+270
+3% +$62.9K 0.99% 28
2019
Q2 		$2.22M Buy
+9,511
New +$2.2M 0.93% 30
2018
Q3 		– Sell
-10,225
Closed -$2.95M – 98
2018
Q2 		$2.95M Sell
10,225
-1,053
-9% -$296K 0.93% 27
2018
Q1 		$3.07M Buy
+11,278
New +$3.5M 1.12% 27

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Empowered Funds's BIIB Position: Q2 2026 in Review

Empowered Funds increased its Biogen (BIIB) stake by 0.79% in Q2 2026, buying an estimated $33.1K and bringing the position to 21,948 shares worth $4.74M. The position accounts for 0.03% of the portfolio, ranked #734.

Empowered Funds first reported a position in BIIB in Q1 2018 and has held it in 24 quarters since. The position peaked at $10.2M in Q4 2025. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Empowered Funds held 21,948 shares of Biogen worth $4.74M as of Q2 2026.
  • Empowered Funds bought 173 Biogen shares in Q2 2026, an estimated $33.1K.
  • Biogen made up 0.03% of Empowered Funds's portfolio in Q2 2026, its #734 holding.
  • Empowered Funds first reported a position in Biogen in Q1 2018 and has held it in 24 quarters since.
  • Empowered Funds's Biogen position peaked at $10.2M in Q4 2025.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.